📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group. (2014)

First Author: Ng CS
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00228-014-1703-0

PubMed Identifier: 24888881

Publication URI: http://europepmc.org/abstract/MED/24888881

Type: Journal Article/Review

Volume: 70

Parent Publication: European journal of clinical pharmacology

Issue: 9

ISSN: 0031-6970